542934 logo

Chandra Bhagat Pharma Limited Stock Price

BSE:542934 Community·₹297.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

542934 Share Price Performance

₹0
-66.95 (-100.00%)
₹0
-66.95 (-100.00%)
Price ₹0

542934 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
0 Rewards

Chandra Bhagat Pharma Limited Key Details

₹493.9m

Revenue

₹357.4m

Cost of Revenue

₹136.6m

Gross Profit

₹130.4m

Other Expenses

₹6.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.82
27.65%
1.26%
69.4%
View Full Analysis

About 542934

Founded
1944
Employees
40
CEO
Hemant Bhagat
WebsiteView website
www.cbcpharma.com

Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its own brand. The company also promotes and markets specialty chemicals, as well as intermediates and active pharmaceuticals ingredients. It also exports its products. The company was founded in 1944 and is headquartered in Mumbai, India.

Recent 542934 News & Updates

Recent updates

No updates